Extracellular vesicles from patients with Acute Coronary Syndrome impact on ischemia-reperfusion injury
The relevance of extracellular vesicles (EV) as mediators of cardiac damage or recovery upon Ischemia Reperfusion Injury (IRI) and Remote Ischemic PreConditioning (RIPC) is controversial. This study aimed to investigate whether serum-derived EV, recovered from patients with Acute Coronary Syndrome (...
Saved in:
| Published in | Pharmacological research Vol. 170; p. 105715 |
|---|---|
| Main Authors | , , , , , , , , , , , , , |
| Format | Journal Article |
| Language | English |
| Published |
Netherlands
Elsevier Ltd
01.08.2021
|
| Subjects | |
| Online Access | Get full text |
Cover
Loading…
| Abstract | The relevance of extracellular vesicles (EV) as mediators of cardiac damage or recovery upon Ischemia Reperfusion Injury (IRI) and Remote Ischemic PreConditioning (RIPC) is controversial. This study aimed to investigate whether serum-derived EV, recovered from patients with Acute Coronary Syndrome (ACS) and subjected to the RIPC or sham procedures, may be a suitable therapeutic approach to prevent IRI during Percutaneous-Coronary-Intervention (PCI). A double-blind, randomized, sham-controlled study (NCT02195726) has been extended, and EV were recovered from 30 patients who were randomly assigned (1:1) to undergo the RIPC- (EV-RIPC) or sham-procedures (EV-naive) before PCI. Patient-derived EV were analyzed by TEM, FACS and western blot. We found that troponin (TnT) was enriched in EV, compared to healthy subjects, regardless of diagnosis. EV-naive induced protection against IRI, both in-vitro and in the rat heart, unlike EV-RIPC. We noticed that EV-naive led to STAT-3 phosphorylation, while EV-RIPC to Erk-1/2 activation in the rat heart. Pre-treatment of the rat heart with specific STAT-3 and Erk-1/2 inhibitors led us to demonstrate that STAT-3 is crucial for EV-naive-mediated protection. In the same model, Erk-1/2 inhibition rescued STAT-3 activation and protection upon EV-RIPC treatment. 84 Human Cardiovascular Disease mRNAs were screened and DUSP6 mRNA was found enriched in patient-derived EV-naive. Indeed, DUSP6 silencing in EV-naive prevented STAT-3 phosphorylation and cardio-protection in the rat heart. This analysis of ACS-patients’ EV proved: (i) EV-naive cardio-protective activity and mechanism of action; (ii) the lack of EV-RIPC-mediated cardio-protection; (iii) the properness of the in-vitro assay to predict EV effectiveness in-vivo.
[Display omitted] |
|---|---|
| AbstractList | The relevance of extracellular vesicles (EV) as mediators of cardiac damage or recovery upon Ischemia Reperfusion Injury (IRI) and Remote Ischemic PreConditioning (RIPC) is controversial. This study aimed to investigate whether serum-derived EV, recovered from patients with Acute Coronary Syndrome (ACS) and subjected to the RIPC or sham procedures, may be a suitable therapeutic approach to prevent IRI during Percutaneous-Coronary-Intervention (PCI). A double-blind, randomized, sham-controlled study (NCT02195726) has been extended, and EV were recovered from 30 patients who were randomly assigned (1:1) to undergo the RIPC- (EV-RIPC) or sham-procedures (EV-naive) before PCI. Patient-derived EV were analyzed by TEM, FACS and western blot. We found that troponin (TnT) was enriched in EV, compared to healthy subjects, regardless of diagnosis. EV-naive induced protection against IRI, both in-vitro and in the rat heart, unlike EV-RIPC. We noticed that EV-naive led to STAT-3 phosphorylation, while EV-RIPC to Erk-1/2 activation in the rat heart. Pre-treatment of the rat heart with specific STAT-3 and Erk-1/2 inhibitors led us to demonstrate that STAT-3 is crucial for EV-naive-mediated protection. In the same model, Erk-1/2 inhibition rescued STAT-3 activation and protection upon EV-RIPC treatment. 84 Human Cardiovascular Disease mRNAs were screened and DUSP6 mRNA was found enriched in patient-derived EV-naive. Indeed, DUSP6 silencing in EV-naive prevented STAT-3 phosphorylation and cardio-protection in the rat heart. This analysis of ACS-patients' EV proved: (i) EV-naive cardio-protective activity and mechanism of action; (ii) the lack of EV-RIPC-mediated cardio-protection; (iii) the properness of the in-vitro assay to predict EV effectiveness in-vivo. The relevance of extracellular vesicles (EV) as mediators of cardiac damage or recovery upon Ischemia Reperfusion Injury (IRI) and Remote Ischemic PreConditioning (RIPC) is controversial. This study aimed to investigate whether serum-derived EV, recovered from patients with Acute Coronary Syndrome (ACS) and subjected to the RIPC or sham procedures, may be a suitable therapeutic approach to prevent IRI during Percutaneous-Coronary-Intervention (PCI). A double-blind, randomized, sham-controlled study (NCT02195726) has been extended, and EV were recovered from 30 patients who were randomly assigned (1:1) to undergo the RIPC- (EV-RIPC) or sham-procedures (EV-naive) before PCI. Patient-derived EV were analyzed by TEM, FACS and western blot. We found that troponin (TnT) was enriched in EV, compared to healthy subjects, regardless of diagnosis. EV-naive induced protection against IRI, both in-vitro and in the rat heart, unlike EV-RIPC. We noticed that EV-naive led to STAT-3 phosphorylation, while EV-RIPC to Erk-1/2 activation in the rat heart. Pre-treatment of the rat heart with specific STAT-3 and Erk-1/2 inhibitors led us to demonstrate that STAT-3 is crucial for EV-naive-mediated protection. In the same model, Erk-1/2 inhibition rescued STAT-3 activation and protection upon EV-RIPC treatment. 84 Human Cardiovascular Disease mRNAs were screened and DUSP6 mRNA was found enriched in patient-derived EV-naive. Indeed, DUSP6 silencing in EV-naive prevented STAT-3 phosphorylation and cardio-protection in the rat heart. This analysis of ACS-patients' EV proved: (i) EV-naive cardio-protective activity and mechanism of action; (ii) the lack of EV-RIPC-mediated cardio-protection; (iii) the properness of the in-vitro assay to predict EV effectiveness in-vivo.The relevance of extracellular vesicles (EV) as mediators of cardiac damage or recovery upon Ischemia Reperfusion Injury (IRI) and Remote Ischemic PreConditioning (RIPC) is controversial. This study aimed to investigate whether serum-derived EV, recovered from patients with Acute Coronary Syndrome (ACS) and subjected to the RIPC or sham procedures, may be a suitable therapeutic approach to prevent IRI during Percutaneous-Coronary-Intervention (PCI). A double-blind, randomized, sham-controlled study (NCT02195726) has been extended, and EV were recovered from 30 patients who were randomly assigned (1:1) to undergo the RIPC- (EV-RIPC) or sham-procedures (EV-naive) before PCI. Patient-derived EV were analyzed by TEM, FACS and western blot. We found that troponin (TnT) was enriched in EV, compared to healthy subjects, regardless of diagnosis. EV-naive induced protection against IRI, both in-vitro and in the rat heart, unlike EV-RIPC. We noticed that EV-naive led to STAT-3 phosphorylation, while EV-RIPC to Erk-1/2 activation in the rat heart. Pre-treatment of the rat heart with specific STAT-3 and Erk-1/2 inhibitors led us to demonstrate that STAT-3 is crucial for EV-naive-mediated protection. In the same model, Erk-1/2 inhibition rescued STAT-3 activation and protection upon EV-RIPC treatment. 84 Human Cardiovascular Disease mRNAs were screened and DUSP6 mRNA was found enriched in patient-derived EV-naive. Indeed, DUSP6 silencing in EV-naive prevented STAT-3 phosphorylation and cardio-protection in the rat heart. This analysis of ACS-patients' EV proved: (i) EV-naive cardio-protective activity and mechanism of action; (ii) the lack of EV-RIPC-mediated cardio-protection; (iii) the properness of the in-vitro assay to predict EV effectiveness in-vivo. The relevance of extracellular vesicles (EV) as mediators of cardiac damage or recovery upon Ischemia Reperfusion Injury (IRI) and Remote Ischemic PreConditioning (RIPC) is controversial. This study aimed to investigate whether serum-derived EV, recovered from patients with Acute Coronary Syndrome (ACS) and subjected to the RIPC or sham procedures, may be a suitable therapeutic approach to prevent IRI during Percutaneous-Coronary-Intervention (PCI). A double-blind, randomized, sham-controlled study (NCT02195726) has been extended, and EV were recovered from 30 patients who were randomly assigned (1:1) to undergo the RIPC- (EV-RIPC) or sham-procedures (EV-naive) before PCI. Patient-derived EV were analyzed by TEM, FACS and western blot. We found that troponin (TnT) was enriched in EV, compared to healthy subjects, regardless of diagnosis. EV-naive induced protection against IRI, both in-vitro and in the rat heart, unlike EV-RIPC. We noticed that EV-naive led to STAT-3 phosphorylation, while EV-RIPC to Erk-1/2 activation in the rat heart. Pre-treatment of the rat heart with specific STAT-3 and Erk-1/2 inhibitors led us to demonstrate that STAT-3 is crucial for EV-naive-mediated protection. In the same model, Erk-1/2 inhibition rescued STAT-3 activation and protection upon EV-RIPC treatment. 84 Human Cardiovascular Disease mRNAs were screened and DUSP6 mRNA was found enriched in patient-derived EV-naive. Indeed, DUSP6 silencing in EV-naive prevented STAT-3 phosphorylation and cardio-protection in the rat heart. This analysis of ACS-patients’ EV proved: (i) EV-naive cardio-protective activity and mechanism of action; (ii) the lack of EV-RIPC-mediated cardio-protection; (iii) the properness of the in-vitro assay to predict EV effectiveness in-vivo. [Display omitted] |
| ArticleNumber | 105715 |
| Author | De Ferrari, Gaetano Maria Brizzi, Maria Felice Ravera, Francesco D’Ascenzo, Fabrizio Caccioppo, Andrea Grosso, Alberto Penna, Claudia Cavallari, Claudia Angelini, Filippo Franchin, Luca Femminò, Saveria Camussi, Giovanni Comità, Stefano Pagliaro, Pasquale |
| Author_xml | – sequence: 1 givenname: Fabrizio surname: D’Ascenzo fullname: D’Ascenzo, Fabrizio organization: Division of Cardiology, Department of Medical Sciences, University of Turin, Turin, Italy – sequence: 2 givenname: Saveria surname: Femminò fullname: Femminò, Saveria organization: Department of Medical Sciences, University of Turin, Turin, Italy – sequence: 3 givenname: Francesco orcidid: 0000-0003-4452-2591 surname: Ravera fullname: Ravera, Francesco organization: Department of Medical Sciences, University of Turin, Turin, Italy – sequence: 4 givenname: Filippo surname: Angelini fullname: Angelini, Filippo organization: Division of Cardiology, Department of Medical Sciences, University of Turin, Turin, Italy – sequence: 5 givenname: Andrea surname: Caccioppo fullname: Caccioppo, Andrea organization: Department of Medical Sciences, University of Turin, Turin, Italy – sequence: 6 givenname: Luca orcidid: 0000-0001-6221-482X surname: Franchin fullname: Franchin, Luca organization: Division of Cardiology, Department of Medical Sciences, University of Turin, Turin, Italy – sequence: 7 givenname: Alberto surname: Grosso fullname: Grosso, Alberto organization: Division of Cardiology, Department of Medical Sciences, University of Turin, Turin, Italy – sequence: 8 givenname: Stefano surname: Comità fullname: Comità, Stefano organization: Department of Clinical and Biological Sciences, University of Turin, Orbassano, Italy – sequence: 9 givenname: Claudia orcidid: 0000-0003-1554-2999 surname: Cavallari fullname: Cavallari, Claudia organization: 2i3T Scarl, University of Turin, Turin, Italy – sequence: 10 givenname: Claudia surname: Penna fullname: Penna, Claudia organization: Department of Clinical and Biological Sciences, University of Turin, Orbassano, Italy – sequence: 11 givenname: Gaetano Maria surname: De Ferrari fullname: De Ferrari, Gaetano Maria organization: Division of Cardiology, Department of Medical Sciences, University of Turin, Turin, Italy – sequence: 12 givenname: Giovanni surname: Camussi fullname: Camussi, Giovanni organization: Department of Medical Sciences, University of Turin, Turin, Italy – sequence: 13 givenname: Pasquale surname: Pagliaro fullname: Pagliaro, Pasquale email: pasquale.pagliaro@unito.it organization: Department of Clinical and Biological Sciences, University of Turin, Orbassano, Italy – sequence: 14 givenname: Maria Felice orcidid: 0000-0003-0944-6992 surname: Brizzi fullname: Brizzi, Maria Felice email: mariafelice.brizzi@unito.it organization: Department of Medical Sciences, University of Turin, Turin, Italy |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/34111564$$D View this record in MEDLINE/PubMed |
| BookMark | eNp9kT1v3DAMhoUiQfP5BzIUGrP4SvpD9gFZgsOlLRCgQ9pZkGW6p4MtuZKc9v59ZFyaoUMmEsTzEuT7XrAT6ywxdoOwQkDxeb-adj6scsgxDaoaqw_sHGEtMsRGnCx9WWRCYHPGLkLYA8C6RPjIzooSEStRnrNf27_RK03DMA_K82cKRg8UeO_dyCcVDdkY-B8Td_xez5H4xnlnlT_wp4PtEkTcjJPSkTvLTdA7Go3KPE3k-zmYZWj3sz9csdNeDYGuX-sl-_mw_bH5mj1-__Jtc_-Y6RIgZpXqBJat0m1V9KJR2DWNaGvAKlciF7pATYB1qYqmV0BK1z3WXbvuc-gQGiou2e1x7-Td75lClGO6Kr2nLLk5yLwqocqXfQn99IrO7UidnLwZ02PynzkJyI-A9i4ET_0bgiCXBOReLgnIJQF5TCCJmv9E2sTko7PJZzO8L707SikZ9GzIy6CT_5o640lH2TnznvwFRhii7w |
| CitedBy_id | crossref_primary_10_1007_s00395_021_00898_0 crossref_primary_10_1186_s42234_024_00153_6 crossref_primary_10_1016_j_phrs_2023_106871 crossref_primary_10_3390_ijms242216197 crossref_primary_10_3389_fcvm_2023_1078290 crossref_primary_10_1080_14728222_2024_2421760 crossref_primary_10_3389_fcell_2022_996887 crossref_primary_10_1016_j_numecd_2022_06_013 crossref_primary_10_1007_s12015_024_10791_7 crossref_primary_10_1016_j_phrs_2023_106718 crossref_primary_10_2147_IJN_S443716 crossref_primary_10_1186_s12916_023_02778_x crossref_primary_10_3390_biology12020308 crossref_primary_10_3389_fcvm_2024_1436764 crossref_primary_10_3389_ti_2024_13212 crossref_primary_10_3390_cimb45030127 crossref_primary_10_1620_tjem_2022_J048 crossref_primary_10_31083_j_rcm2301023 crossref_primary_10_1002_mba2_103 crossref_primary_10_1007_s00441_022_03605_0 crossref_primary_10_3390_cardiogenetics15010002 crossref_primary_10_3390_ph17030337 crossref_primary_10_1080_14728222_2025_2454617 crossref_primary_10_3389_fcvm_2024_1425159 crossref_primary_10_1016_j_cca_2023_117374 crossref_primary_10_31083_j_rcm2506222 crossref_primary_10_3390_ijms221910270 crossref_primary_10_1016_j_bbrc_2021_11_028 crossref_primary_10_1002_mco2_454 |
| Cites_doi | 10.1038/oncsis.2017.52 10.1242/dev.157206 10.1007/s10495-019-01546-8 10.3892/ijmm.2016.2759 10.1097/ALN.0000000000000807 10.1155/2018/3290372 10.1080/20013078.2018.1535750 10.1016/j.vph.2020.106790 10.1039/C5OB01451D 10.1371/journal.pone.0083395 10.1371/journal.pone.0228948 10.1016/j.cyto.2016.05.019 10.1002/cyto.a.22647 10.1016/j.ejphar.2016.06.038 10.1152/ajpheart.00374.2004 10.1161/01.CIR.74.5.1124 10.1016/j.cardiores.2005.04.007 10.1007/s00395-016-0588-8 10.3390/ijms20092164 10.1161/CIRCULATIONAHA.105.558122 10.1007/s00395-016-0543-8 10.1161/CIRCRESAHA.117.306878 10.3390/biomedicines8070218 10.1016/j.yjmcc.2014.05.001 10.1016/j.jacc.2005.04.044 10.1007/s00395-014-0423-z 10.1093/carcin/bgq020 10.1111/bph.14839 10.5551/jat.32326 10.3389/fimmu.2018.01326 10.1530/JOE-15-0201 10.4244/EIJY19M01_01 10.1152/ajpheart.01064.2002 10.3390/ijms20205024 10.1016/j.yjmcc.2009.01.003 10.1155/2020/9219825 10.3389/fphys.2018.01169 10.2174/1381612811319250004 10.1152/ajpheart.1994.267.6.H2383 10.1186/1479-5876-9-47 10.1038/nrcardio.2016.5 10.1074/jbc.M110.128157 10.1007/s00395-017-0662-x 10.1124/pr.113.008300 10.1182/blood-2007-03-078709 10.1161/CIRCRESAHA.117.311326 10.1093/cvr/cvp185 10.1007/s00395-010-0133-0 10.1161/01.RES.0000178451.08719.5b 10.1093/cvr/cvy314 10.1016/j.ijcard.2017.12.033 10.3389/fphys.2018.00875 10.1056/NEJMra071667 10.1016/j.cardiores.2003.09.031 10.3390/polym10020211 10.1152/ajpheart.00152.2018 10.1038/ncpcardio0632 10.1007/978-981-10-4397-0_19 10.1161/CIRCRESAHA.116.305348 10.1161/CIRCRESAHA.111.259556 10.1016/j.apsb.2016.02.001 10.1007/s00395-010-0124-1 10.1161/CIRCRESAHA.111.255604 10.2203/dose-response.14-035.Whittaker 10.1007/s11060-013-1084-8 10.1038/srep30110 10.1161/CIRCRESAHA.117.310820 10.1038/s41598-018-33862-5 10.1007/s11010-020-03936-y 10.1161/01.CIR.87.3.893 10.2459/JCM.0b013e328358c8eb 10.1016/S0140-6736(19)32039-2 10.1097/HJH.0b013e32833b558c 10.3390/ijms20092140 10.1016/j.omtm.2019.01.001 10.3390/ijms19113572 10.4161/auto.21036 10.1016/j.atherosclerosis.2011.12.025 10.3390/cells10010013 10.1074/jbc.M806085200 10.1111/aas.13296 10.1089/ars.2019.7923 10.1016/j.yjmcc.2014.01.004 10.1016/j.bbrc.2020.08.106 |
| ContentType | Journal Article |
| Copyright | 2021 The Authors Copyright © 2021 The Authors. Published by Elsevier Ltd.. All rights reserved. |
| Copyright_xml | – notice: 2021 The Authors – notice: Copyright © 2021 The Authors. Published by Elsevier Ltd.. All rights reserved. |
| DBID | 6I. AAFTH AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 |
| DOI | 10.1016/j.phrs.2021.105715 |
| DatabaseName | ScienceDirect Open Access Titles Elsevier:ScienceDirect:Open Access CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Pharmacy, Therapeutics, & Pharmacology |
| EISSN | 1096-1186 |
| ExternalDocumentID | 34111564 10_1016_j_phrs_2021_105715 S1043661821002991 |
| Genre | Randomized Controlled Trial Research Support, Non-U.S. Gov't Journal Article |
| GroupedDBID | --- --K --M .GJ .~1 0R~ 0SF 0ZK 123 1B1 1RT 1~. 1~5 29O 3O- 4.4 457 4G. 53G 5RE 5VS 6I. 7-5 71M 8P~ 9JM AACTN AAEDT AAEDW AAFTH AAIAV AAIKJ AAKOC AALRI AAOAW AAQFI AAQXK AATCM AAXUO ABFNM ABFRF ABJNI ABMAC ABOCM ABXDB ABYKQ ABZDS ACDAQ ACGFO ACGFS ACRLP ADBBV ADEZE ADFGL ADMUD AEBSH AEFWE AEKER AENEX AFKWA AFTJW AFXIZ AGHFR AGUBO AGYEJ AHHHB AIEXJ AIKHN AITUG AJBFU AJOXV ALCLG ALMA_UNASSIGNED_HOLDINGS AMFUW AMRAJ ASPBG AVWKF AXJTR AZFZN BKOJK BLXMC C45 CAG COF CS3 DM4 DU5 EBS EFBJH EFLBG EJD EO8 EO9 EP2 EP3 F5P FDB FEDTE FGOYB FIRID FNPLU FYGXN G-2 G-Q GBLVA GROUPED_DOAJ HMT HVGLF HX~ HZ~ IHE J1W KOM L7B LG5 M33 M41 MO0 N9A O-L O9- OAUVE OGGZJ OVD OZT P-8 P-9 P2P PC. Q38 R2- RIG ROL RPZ SCC SDF SDG SDP SES SEW SPCBC SPT SSP SSZ T5K TEORI UNMZH WUQ XPP ZA5 ZU3 ZXP ~G- AATTM AAXKI AAYWO AAYXX ABWVN ACRPL ACVFH ADCNI ADNMO ADVLN AEIPS AEUPX AFJKZ AFPUW AGCQF AGQPQ AGRNS AIGII AIIUN AKBMS AKRWK AKYEP ANKPU APXCP BNPGV CITATION SSH CGR CUY CVF ECM EIF NPM 7X8 EFKBS |
| ID | FETCH-LOGICAL-c400t-5ad614bacb53f68a1d886b70152a626c31ce0174a38fa0eac7f17db9f20d108e3 |
| IEDL.DBID | .~1 |
| ISSN | 1043-6618 1096-1186 |
| IngestDate | Mon Jul 21 09:26:06 EDT 2025 Thu Apr 03 07:00:31 EDT 2025 Tue Jul 01 03:33:50 EDT 2025 Thu Apr 24 23:00:09 EDT 2025 Fri Feb 23 02:43:47 EST 2024 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Keywords | Salvage pathways Extracellular vesicles ACS Ischemia/reperfusion injury |
| Language | English |
| License | This is an open access article under the CC BY license. Copyright © 2021 The Authors. Published by Elsevier Ltd.. All rights reserved. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c400t-5ad614bacb53f68a1d886b70152a626c31ce0174a38fa0eac7f17db9f20d108e3 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 ObjectType-Undefined-3 |
| ORCID | 0000-0001-6221-482X 0000-0003-4452-2591 0000-0003-0944-6992 0000-0003-1554-2999 |
| OpenAccessLink | https://www.sciencedirect.com/science/article/pii/S1043661821002991 |
| PMID | 34111564 |
| PQID | 2540520152 |
| PQPubID | 23479 |
| ParticipantIDs | proquest_miscellaneous_2540520152 pubmed_primary_34111564 crossref_primary_10_1016_j_phrs_2021_105715 crossref_citationtrail_10_1016_j_phrs_2021_105715 elsevier_sciencedirect_doi_10_1016_j_phrs_2021_105715 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | August 2021 2021-08-00 20210801 |
| PublicationDateYYYYMMDD | 2021-08-01 |
| PublicationDate_xml | – month: 08 year: 2021 text: August 2021 |
| PublicationDecade | 2020 |
| PublicationPlace | Netherlands |
| PublicationPlace_xml | – name: Netherlands |
| PublicationTitle | Pharmacological research |
| PublicationTitleAlternate | Pharmacol Res |
| PublicationYear | 2021 |
| Publisher | Elsevier Ltd |
| Publisher_xml | – name: Elsevier Ltd |
| References | Hausenloy, Kharbanda, Møller, Ramlall, Aarøe, Butler, Bulluck, Clayton, Dana, Dodd, Engstrom, Evans, Lassen, Christensen, Garcia-Ruiz, Gorog, Hjort, Houghton, Ibanez, Knight, Lippert, Lønborg, Maeng, Milasinovic, More, Nicholas, Jensen, Perkins, Radovanovic, Rakhit, Ravkilde, Ryding, Schmidt, Riddervold, Sørensen, Stankovic, Varma, Webb, Terkelsen, Greenwood, Yellon, Bøtker, Junker, Kaltoft, Madsen, Christiansen, Jakobsen, Carstensen, Kristensen, Thim, Pedersen, Korsgaard, Iversen, Jørgensen, Joshi, Pedersen, Tilsted, Alzuhairi, Saunamäki, Holmvang, Ahlehof, Sørensen, Helqvist, Mark, Villadsen, Raungaard, Thuesen, Christiansen, Freeman, Jensen, Skov, Aziz, Hansen, Ellert, Veien, Pedersen, Hansen, Ahlehoff, Cappelen, Wittrock, Hansen, Ankersen, Hedegaard, Kempel, Kaus, Erntgaard, Pedersen, Giebner, Hansen, Radosavljevic-Radovanovic, Prodanovic, Savic, Pejic, Matic, Uscumlic, Subotic, Lasica, Vukcevic, Suárez, Samaniego, Morís, Segovia, Hernández, Lozano, Pascual, Vegas-Valle, Rozado, Rondán, Avanzas, del Valle, Padrón, García-Castro, Arango, Medina-Cameán, Fente, Muriel-Velasco, Pomar-Amillo, Roza, Martínez-Fernández, Buelga-Díaz, Fernández-Gonzalo, Fernández, Díaz-González, Martinez-González, Iglesias-Llaca, Viribay, Fernández-Mallo, Hermosa, Martínez-Bastida, Goitia-Martín, Vega-Fernández, Tresguerres, Rodil-Díaz, Villar-Fernández, Alberdi, Abella-Ovalle, de la Roz, Fernández-Carral, Naves, Peláez, Fuentes, García-Alonso, Villanueva, Vinagrero, Vázquez-Suárez, Martínez-Valle, Nonide, Pozo-López, Bernardo-Alba, Galván-Núñez, Martínez-Pérez, Castro, Suárez-Coto, Suárez-Noriega, Guinea, Quintana, de Cima, Hedrera, Laca, Llorente-Álvarez, Pascual, Cimas, Mathur, McFarlane-Henry, Leonard, Veerapen, Westwood, Colicchia, Prossora, Andiapen, Mohiddin, Lenzi, Chong, Francis, Pine, Jamieson-Leadbitter, Neal, Din, McLeod, Roberts, Polokova, Longman, Penney, Lakeman, Wells, Hopper, Coward, O’Kane, Harkins, Guyatt, Kennard, Orr, Horler, Morris, Walvin, Snow, Cunnington, Burd, Gowing, Krishnamurthy, Harland, Norfolk, Johnstone, Newman, Reed, O’Neill, Greenwood, Cuxton, Corrigan, Somers, Anderson, Burtonwood, Bijsterveld, Brogan, Ryan, Kodoth, Khan, Sebastian, Gorog, Boyle, Shepherd, Hamid, Farag, Spinthakis, Waitrak, Sousa, Bhatti, Oliver, Walshe, Odedra, Gue, Kanji, Ryding, Ratcliffe, Merrick, Horwood, Sarti, Maart, Moore, Dockerty, Baucutt, Pitcher, Ilsley, Clarke, Germon, Gomes, Clare, Nair, Staines, Nicholson, Watkinson, Gallagher, Nelthorpe, Musselwhite, Grosser, Stimson, Eaton, Heppell, Turney, Horner, Schumacher, Moon, Mota, O’Donnell, Panicker, Musa, Tapp, Krishnamoorthy, Ansell, Ali, Hyndman, Banerjee, Been, Mackenzie, McGregor, Hildick-Smith, Champney, Ingoldby, Keate, Bennett, Skipper, Gregory, Harfield, Mudd, Wragg, Barmby, Grech, Hall, Middle, Barker, Fofie, Gunn, Housley, Cockayne, Weatherlley, Theodorou, Wheeldon, Fati, Storey, Richardson, Iqbal, Adam, Brett, Agyemang, Tawiah, Hogrefe, Raju, Braybrook, Gracey, Waldron, Holloway, Burunsuzoglu, Sidgwick, Hetherington, Beirnes, Fernandez, Lazar, Knighton, Rai, Hoare, Breeze, Martin, Andrews, Patale, Bennett, Smallwood, Radford, Cotton, Martins, Wallace, Milgate, Munir, Metherell, Cottam, Massey, Copestick, Delaney, Wain, Sandhu, Emery, Hall, Bucciarelli-Ducci, Besana, Hussein, Bell, Gill, Bales, Polwarth, East, Smith, Oliveira, Victor, Woods, Hoole, Ramos, Sevillano, Nicholson, Solieri, Redman, Byrne, Joyce, Riches, Davies, Allen, Saclot, Ocampo, Vertue, Christmas, Koothoor, Gamma, Alvares, Pepper, Kobson, Reeve, Malik, Chester, Saunders, Mojela, Smee, Davies, Davies, Clifford, Dias, Kaur, Moreira, Ahmad, Tomlinson, Pengelley, Bidle, Spence, Al-Lamee, Phuyal, Abbass, Bose, Elliott, Foundun, Chung, Freestone, Lee, Elshiekh, Pulikal, Bhatre, Douglas, Kaeng, Pitt, Watkins, Gill, Hartley, Lucking, Moreby, Darby, Corps, Parsons, De Mance, Fahrai, Turner, Langrish, Gaughran, Wolyrum, Azkhalil, Bates, Given, Kharbanda, Douthwaite, Lloyd, Neubauer, Barker, Suttling, Turner, Smith, Longbottom, Ross, Cunliffe, Cox, Whitehead, Hudson, Jones, Drew, Chant, Haworth, Capel, Austin, Howe, Smith, Hobson, Strike, Griffiths, Anantharam, Jack, Thornton, Hodgson, Jennison, McSkeane, Smith, Shaw, Leathers, Armstrong, Carruthers, Simpson, Smith, Hodierne, Kelly, Barclay, Scott, Gregson, Buchanan, McCormick, Kelsall, Mcarthy, Taylor, Thompson, Shelton, Moore, Tomlinson, Thambi, Cooper, Oakes, Deen, Relph, Prentice, Hall, Dillon, Meadows, Frank, Markham-Jones, Thomas, Gale, Denman, O’Connor, Hindle, Jackson-Lawrence, Warner, Lee, Upton, Elston, Lee, Venugopal, Finch, Fleming, Whiteside, Pemberton, Wilkinson, Sebastian, Riedel, Giuffrida, Burnett, Spickett, Glen, Brown, Thornborough, Pedley, Morgan, Waddington, Brennan, Brady, Preston, Loder, Vlad, Laurence, Smit, Dimond, Hayes, Paddy, Crause, Amed, Kaur-Babooa, Rakhit, Kotecha, Fayed, Pavlidis, Prendergast, Clapp, Perara, Atkinson, Ellis, Wilson, Gibson, Smith, Khawaja, Sanchez-Vidal, Redwood, Jones, Tipping, Oommen, Hendry, Fath-Orboubadi, Phillips, Kolakaluri, Sherwood, Mackie, Aleti, Charles, Roy, Henderson, Stables, Marber, Berry, Redington, Thygesen, Andersen, Berry, Copas, Meade, Kelbæk, Bueno, von Weitzel-Mudersbach, Andersen, Ludman, Cruden, Topic, Mehmedbegovic, de la Hera Galarza, Robertson, Dyck, Chu, Astarci, Jamal, Hetherington, Collier (bib32) 2019; 394 Han, Hu, Sun, Bian, Tang, Fang (bib58) 2020; 476 Femminò, Penna, Bessone, Caldera, Dhakar, Cau, Pagliaro, Cavalli, Trotta (bib57) 2018; 10 Giricz, Varga, Baranyai, Sipos, Pálóczi, Kittel, Buzás, Ferdinandy (bib74) 2014; 68 Armstrong (bib26) 2004; 61 Mooberry, Key (bib39) 2016; 89 Kleinbongard, Bøtker, Ovize, Hausenloy, Heusch (bib30) 2020; 177 Basilico, Mondani, Parapini, Speciale, Ferrante, Taramelli (bib56) 2004; 95 Garama, White, Balic, Gough (bib80) 2016; 87 Ng, Ng, Yeap, Badrian, Tsoutsman, McMullen, Semsarian, Bogoyevitch (bib81) 2011; 286 Brill, Dashevsky, Rivo, Gozal, Varon (bib38) 2005; 67 Femminò, Penna, Margarita, Comità, Brizzi, Pagliaro (bib43) 2020; 135 Gallo, Vitacolonna, Bonzano, Comoglio, Crepaldi (bib75) 2019; 20 Rossello, Yellon (bib17) 2018; 113 Lecour (bib21) 2009; 46 Breivik, Helgeland, Aarnes, Mrdalj, Jonassen (bib73) 2011; 106 Gough, Koetz, Levy (bib16) 2013; 8 Akers, Gonda, Kim, Carter, Chen (bib37) 2013; 113 Ma, Liu, Shen, Zhang, Pan (bib46) 2015; 8 Garcia-Dorado, Ruiz-Meana, Piper (bib5) 2009; 83 Skyschally, Gent, Amanakis, Schulte, Kleinbongard, Heusch (bib13) 2015; 117 Murry, Jennings, Reimer (bib7) 1986; 74 Whittaker, Przyklenk (bib77) 2014; 12 Nikolaou, Efentakis, Abu Qourah, Femminò, Makridakis, Kanaki, Varela, Tsoumani, Davos, Dimitriou, Tasouli, Dimitriadis, Kostomitsopoulos, Zuurbier, Vlahou, Klinakis, Brizzi, Iliodromitis, Andreadou (bib60) 2021; 34 Frey, Klaassen, Ochsenfarth, Murke, Thielmann, Kottenberg, Kleinbongard, Klenke, Engler, Heusch, Giebel, Peters (bib45) 2019; 63 Zhao, Corvera, Halkos, Kerendi, Wang, Guyton, Vinten-Johansen (bib8) 2003; 285 Moretti, Cerrato, Cavallero, Lin, Rossi, Picchi, Sanguineti, Ugo, Palazzuoli, Bertaina, Presbitero, Shao-liang, Pozzi, Giammaria, Limbruno, Lefèvre, Gasparetto, Garbo, Omedè, Sheiban, Escaned, Biondi-Zoccai, Gaita, Perl, D’Ascenzo (bib49) 2018; 257 Hausenloy, Barrabes, Bøtker, Davidson, Di Lisa, Downey, Engstrom, Ferdinandy, Carbrera-Fuentes, Heusch, Ibanez, Iliodromitis, Inserte, Jennings, Kalia, Kharbanda, Lecour, Marber, Miura, Ovize, Perez-Pinzon, Piper, Przyklenk, Schmidt, Redington, Ruiz-Meana, Vilahur, Vinten-Johansen, Yellon, Garcia-Dorado (bib6) 2016; 111 Barani, Rajasingh, Rajasingh (bib33) 2017; 998 Hausenloy, Yellon (bib28) 2016; 13 Ferdinandy, Hausenloy, Heusch, Baxter, Schulz (bib29) 2014; 66 Zhang, Kobayashi, Borczuk, Leidner, LaFramboise, Levine, Halmos (bib62) 2010; 31 Spannbauer, Traxler, Lukovic, Zlabinger, Winkler, Gugerell, Ferdinandy, Hausenloy, Pavo, Emmert, Hoerstrup, Jakab, Gyöngyösi, Riesenhuber (bib35) 2019; 20 Li, Rohailla, Gelber, Rutka, Sabah, Gladstone, Wei, Hu, Kharbanda, Redington (bib85) 2014; 109 Liu, Peters, Urban, Knowlton, Napierala, Gabrysiak (bib65) 2020; 533 Pomatto, Bussolati, D’Antico, Ghiotto, Tetta, Brizzi, Camussi (bib64) 2019; 13 Yellon, Hausenloy (bib3) 2007; 357 Missinato, Saydmohammed, Zuppo, Rao, Opie, Kühn, Tsang (bib89) 2018; 145 Russo, Femminò, Barale, Tullio, Geuna, Cavalot, Pagliaro, Penna (bib61) 2018; 9 Loyer, Zlatanova, Devue, Yin, Howangyin, Klaihmon, Guerin, Khelouf, Vilar, Zannis, Fleischmann, Hwang, Park, Lee, Menasché, Silvestre, Boulanger (bib44) 2018; 123 Ghaderi, Alidadiani, Dilaver, Heidari, Parvizi, Rahbarghazi, Soleimani-Rad, Baradaran (bib19) 2019; 24 Yang, Liu, Lu, Adah, Yu, Zhao, Yao, Qin, Qin, Chen (bib72) 2017; 6 Su, Aldawsari, Amiji (bib71) 2016; 6 Ma, Chen, Chen, Meng, Sun, Shao, Yu, Huang, Hu, Yang, Yang, Shen (bib86) 2018; 2018 Przyklenk, Bauer, Ovize, Kloner, Whittaker (bib11) 1993; 87 Abel, Murke, Gaida, Garnier, Ochsenfarth, Theiss, Thielmann, Kleinbongard, Giebel, Peters, Frey (bib47) 2020; 15 Przyklenk, Whittaker (bib12) 2013; 14 Sharkovska, Kalk, Lawrenz, Godes, Hoffmann, Wellkisch, Geschka, Relle, Hocher, Stasch (bib27) 2010; 28 Maillet, Purcell, Sargent, York, Bueno, Molkentin (bib88) 2008; 283 Hildebrandt, Kreienkamp, Gent, Kahlert, Heusch, Kleinbongard (bib50) 1970; 1 Wang, Zhang, Liang, Xu, Qiu, Tian, Guo, Jia, Xing, Chen, Xiang, Liu (bib76) 2016; 788 Loukogeorgakis, Panagiotidou, Broadhead, Donald, Deanfield, MacAllister (bib10) 2005; 2 Ito (bib4) 2006; 3 Haller, Jäger, Piackova, Sztulman, Wegberger, Wojta, Gyöngyösi, Kiss, Podesser, Spittler, Huber (bib48) 2020; 8 Wendt, Goetzenich, Goettsch, Stoppe, Bleilevens, Kraemer, Benstoem (bib41) 2018; 8 Heusch, Musiolik, Gedik, Skyschally (bib79) 2011; 109 Lawson, Vicencio, Yellon, Davidson (bib67) 2016; 228 Qiao, Olson, Paterson, Yan, Zaja, Liu, Riess, Kersten, Liang, Warltier, Bosnjak, Ge (bib87) 2015; 123 Jung, Sörensson, Saleh, Arheden, Rydén, Pernow (bib70) 2012; 221 Ma, Liu, Foyil, Godar, Weinheimer, Diwan (bib25) 2012; 8 Thery, Witwer, Aikawa, Acaraz (bib36) 2018; 7 Caccioppo, Franchin, Grosso, Angelini, D’A Lecour (10.1016/j.phrs.2021.105715_bib21) 2009; 46 Chen (10.1016/j.phrs.2021.105715_bib69) 2011; 9 Nomura (10.1016/j.phrs.2021.105715_bib40) 2016; 23 Femminò (10.1016/j.phrs.2021.105715_bib43) 2020; 135 Hildebrandt (10.1016/j.phrs.2021.105715_bib50) 1970; 1 Wang (10.1016/j.phrs.2021.105715_bib76) 2016; 788 Garcia-Dorado (10.1016/j.phrs.2021.105715_bib5) 2009; 83 Spannbauer (10.1016/j.phrs.2021.105715_bib35) 2019; 20 O’Sullivan (10.1016/j.phrs.2021.105715_bib22) 2016; 111 Staat (10.1016/j.phrs.2021.105715_bib9) 2005; 112 Rossello (10.1016/j.phrs.2021.105715_bib17) 2018; 113 Sharkovska (10.1016/j.phrs.2021.105715_bib27) 2010; 28 Yang (10.1016/j.phrs.2021.105715_bib72) 2017; 6 Ferdinandy (10.1016/j.phrs.2021.105715_bib29) 2014; 66 Heusch (10.1016/j.phrs.2021.105715_bib15) 2015; 116 Akers (10.1016/j.phrs.2021.105715_bib37) 2013; 113 Penna (10.1016/j.phrs.2021.105715_bib53) 2020; 10 Davidson (10.1016/j.phrs.2021.105715_bib34) 2019; 115 Qiao (10.1016/j.phrs.2021.105715_bib87) 2015; 123 Hausenloy (10.1016/j.phrs.2021.105715_bib18) 2005; 288 Missinato (10.1016/j.phrs.2021.105715_bib89) 2018; 145 Costa (10.1016/j.phrs.2021.105715_bib14) 2005; 97 Ha (10.1016/j.phrs.2021.105715_bib66) 2016; 6 Hausenloy (10.1016/j.phrs.2021.105715_bib24) 2013; 19 Ng (10.1016/j.phrs.2021.105715_bib81) 2011; 286 Li (10.1016/j.phrs.2021.105715_bib85) 2014; 109 Whittaker (10.1016/j.phrs.2021.105715_bib77) 2014; 12 Abel (10.1016/j.phrs.2021.105715_bib47) 2020; 15 Kleinbongard (10.1016/j.phrs.2021.105715_bib30) 2020; 177 Heusch (10.1016/j.phrs.2021.105715_bib20) 2012; 6 Zhao (10.1016/j.phrs.2021.105715_bib8) 2003; 285 Loyer (10.1016/j.phrs.2021.105715_bib44) 2018; 123 Osteikoetxea (10.1016/j.phrs.2021.105715_bib55) 2015; 13 Hausenloy (10.1016/j.phrs.2021.105715_bib32) 2019; 394 Ma (10.1016/j.phrs.2021.105715_bib86) 2018; 2018 Gallo (10.1016/j.phrs.2021.105715_bib75) 2019; 20 Liu (10.1016/j.phrs.2021.105715_bib65) 2020; 533 Heusch (10.1016/j.phrs.2021.105715_bib2) 2017; 38 Wiklander (10.1016/j.phrs.2021.105715_bib54) 2018; 9 Wendt (10.1016/j.phrs.2021.105715_bib41) 2018; 8 Han (10.1016/j.phrs.2021.105715_bib58) 2020; 476 Yellon (10.1016/j.phrs.2021.105715_bib3) 2007; 357 Ghaderi (10.1016/j.phrs.2021.105715_bib19) 2019; 24 Andriolo (10.1016/j.phrs.2021.105715_bib68) 2018; 9 Thery (10.1016/j.phrs.2021.105715_bib36) 2018; 7 Giricz (10.1016/j.phrs.2021.105715_bib74) 2014; 68 Heusch (10.1016/j.phrs.2021.105715_bib31) 2017; 120 Caccioppo (10.1016/j.phrs.2021.105715_bib42) 2019; 20 Mooberry (10.1016/j.phrs.2021.105715_bib39) 2016; 89 Przyklenk (10.1016/j.phrs.2021.105715_bib11) 1993; 87 Barani (10.1016/j.phrs.2021.105715_bib33) 2017; 998 Neumann (10.1016/j.phrs.2021.105715_bib1) 2020; 14 Murry (10.1016/j.phrs.2021.105715_bib7) 1986; 74 Hausenloy (10.1016/j.phrs.2021.105715_bib6) 2016; 111 Deregibus (10.1016/j.phrs.2021.105715_bib52) 2016; 38 Frey (10.1016/j.phrs.2021.105715_bib45) 2019; 63 Deregibus (10.1016/j.phrs.2021.105715_bib82) 2007; 110 Russo (10.1016/j.phrs.2021.105715_bib61) 2018; 9 Su (10.1016/j.phrs.2021.105715_bib71) 2016; 6 Hausenloy (10.1016/j.phrs.2021.105715_bib28) 2016; 13 Penna (10.1016/j.phrs.2021.105715_bib59) 2020; 2020 Garama (10.1016/j.phrs.2021.105715_bib80) 2016; 87 Ma (10.1016/j.phrs.2021.105715_bib25) 2012; 8 Przyklenk (10.1016/j.phrs.2021.105715_bib12) 2013; 14 Takahashi (10.1016/j.phrs.2021.105715_bib83) 2014; 127 Ito (10.1016/j.phrs.2021.105715_bib4) 2006; 3 Ma (10.1016/j.phrs.2021.105715_bib46) 2015; 8 Maillet (10.1016/j.phrs.2021.105715_bib88) 2008; 283 Jung (10.1016/j.phrs.2021.105715_bib70) 2012; 221 Armstrong (10.1016/j.phrs.2021.105715_bib26) 2004; 61 Zhang (10.1016/j.phrs.2021.105715_bib62) 2010; 31 Pipicz (10.1016/j.phrs.2021.105715_bib78) 2018; 19 Moretti (10.1016/j.phrs.2021.105715_bib49) 2018; 257 Loukogeorgakis (10.1016/j.phrs.2021.105715_bib10) 2005; 2 Femminò (10.1016/j.phrs.2021.105715_bib57) 2018; 10 Breivik (10.1016/j.phrs.2021.105715_bib73) 2011; 106 Boengler (10.1016/j.phrs.2021.105715_bib23) 2010; 105 Brill (10.1016/j.phrs.2021.105715_bib38) 2005; 67 Pomatto (10.1016/j.phrs.2021.105715_bib64) 2019; 13 Skyschally (10.1016/j.phrs.2021.105715_bib51) 2018; 315 Basilico (10.1016/j.phrs.2021.105715_bib56) 2004; 95 Ytrehus (10.1016/j.phrs.2021.105715_bib63) 1994; 267 Lawson (10.1016/j.phrs.2021.105715_bib67) 2016; 228 Haller (10.1016/j.phrs.2021.105715_bib48) 2020; 8 Wang (10.1016/j.phrs.2021.105715_bib84) 2014; 74 Gough (10.1016/j.phrs.2021.105715_bib16) 2013; 8 Nikolaou (10.1016/j.phrs.2021.105715_bib60) 2021; 34 Skyschally (10.1016/j.phrs.2021.105715_bib13) 2015; 117 Heusch (10.1016/j.phrs.2021.105715_bib79) 2011; 109 |
| References_xml | – volume: 1 start-page: 3 year: 1970 end-page: 13 ident: bib50 article-title: Kinetics and signal activation properties of circulating factor(s) from healthy volunteers undergoing remote ischemic pre-conditioning publication-title: JACC: Basic Transl. Sci. – volume: 123 start-page: 786 year: 2015 end-page: 798 ident: bib87 article-title: MicroRNA-21 mediates isoflurane-induced cardioprotection against ischemia-reperfusion injury via Akt/Nitric oxide synthase/mitochondrial permeability transition pore pathway publication-title: Anesthesiology – volume: 109 start-page: 423 year: 2014 ident: bib85 article-title: Microrna-144 is a circulating effector of remote ischemic preconditioning publication-title: Basic Res. Cardiol. – volume: 87 start-page: 20 year: 2016 end-page: 25 ident: bib80 article-title: Mitochondrial STAT3: powering up a potent factor publication-title: Cytokine – volume: 9 start-page: 1169 year: 2018 ident: bib68 article-title: Exosomes from human cardiac progenitor cells for therapeutic applications: development of a GMP-grade manufacturing method publication-title: Front. Physiol. – volume: 20 start-page: 2140 year: 2019 ident: bib35 article-title: Effect of ischemic preconditioning and postconditioning on exosome-rich fraction microrna levels, in relation with electrophysiological parameters and ventricular arrhythmia in experimental closed-chest reperfused myocardial infarction publication-title: Int. J. Mol. Sci. – volume: 38 start-page: 1359 year: 2016 end-page: 1366 ident: bib52 article-title: Charge-based precipitation of extracellular vesicles publication-title: Int. J. Mol. Med. – volume: 357 start-page: 1121 year: 2007 end-page: 1135 ident: bib3 article-title: Myocardial reperfusion injury publication-title: N. Engl. J. Med. – volume: 83 start-page: 165 year: 2009 end-page: 168 ident: bib5 article-title: Lethal reperfusion injury in acute myocardial infarction: facts and unresolved issues publication-title: Cardiovasc. Res. – volume: 20 start-page: 5024 year: 2019 ident: bib42 article-title: Ischemia reperfusion injury: mechanisms of damage/protection and novel strategies for cardiac recovery/regeneration publication-title: Int. J. Mol. Sci. – volume: 135 year: 2020 ident: bib43 article-title: Extracellular vesicles and cardiovascular system: biomarkers and cardioprotective effectors publication-title: Vasc. Pharmacol. – volume: 123 start-page: 100 year: 2018 end-page: 106 ident: bib44 article-title: Intra-cardiac release of extracellular vesicles shapes inflammation following myocardial infarction short communication publication-title: Circ. Res. – volume: 9 start-page: 1326 year: 2018 ident: bib54 article-title: Systematic methodological evaluation of a multiplex bead-based flow cytometry assay for detection of extracellular vesicle surface signatures publication-title: Front. Immunol. – volume: 6 start-page: 30110 year: 2016 ident: bib71 article-title: Pancreatic cancer cell exosome-mediated macrophage reprogramming and the role of MicroRNAs 155 and 125b2 transfection using nanoparticle delivery systems publication-title: Sci. Rep. – volume: 19 start-page: 4544 year: 2013 end-page: 4563 ident: bib24 article-title: Cardioprotection techniques: preconditioning, postconditioning and remote con-ditioning (basic science) publication-title: Curr. Pharm. Des. – volume: 34 start-page: 551 year: 2021 end-page: 571 ident: bib60 article-title: Chronic empagliflozin treatment reduces myocardial infarct size in nondiabetic mice through STAT-3-mediated protection on microvascular endothelial cells and reduction of oxidative stress publication-title: Antioxid. Redox Signal. – volume: 998 start-page: 285 year: 2017 end-page: 307 ident: bib33 article-title: Exosomes: outlook for future cell-free cardiovascular disease therapy publication-title: Adv. Exp. Med. Biol. – volume: 12 start-page: 650 year: 2014 end-page: 663 ident: bib77 article-title: From ischemic conditioning to ‘hyperconditioning’: clinical phenomenon and basic science opportunity publication-title: Dose-Response – volume: 87 start-page: 893 year: 1993 end-page: 899 ident: bib11 article-title: Regional ischemic “preconditioning” protects remote virgin myocardium from subsequent sustained coronary occlusion publication-title: Circulation – volume: 2018 year: 2018 ident: bib86 article-title: MicroRNA-132, delivered by mesenchymal stem cell-derived exosomes, promote angiogenesis in myocardial infarction publication-title: Stem Cells Int. – volume: 117 start-page: 279 year: 2015 end-page: 288 ident: bib13 article-title: Across-species transfer of protection by remote ischemic preconditioning with species-specific myocardial signal transduction by reperfusion injury salvage kinase and survival activating factor enhancement pathways publication-title: Circ. Res. – volume: 20 start-page: 2164 year: 2019 ident: bib75 article-title: ERK: A key player in the pathophysiology of cardiac hypertrophy publication-title: Int. J. Mol. Sci. – volume: 476 start-page: 689 year: 2020 end-page: 698 ident: bib58 article-title: MicroRNA-20a-5p suppresses tumor angiogenesis of non-small cell lung cancer through RRM2-mediated PI3K/Akt signaling pathway publication-title: Mol. Cell. Biochem. – volume: 116 start-page: 674 year: 2015 end-page: 699 ident: bib15 article-title: Molecular basis of cardioprotection signal transduction in ischemic pre-, post-, and remote conditioning publication-title: Circ. Res. – volume: 8 start-page: 218 year: 2020 ident: bib48 article-title: Changes in circulating extracellular vesicles in patients with st-elevation myocardial infarction and potential effects of remote ischemic conditioning-a randomized controlled trial publication-title: Biomedicines – volume: 2020 year: 2020 ident: bib59 article-title: Ticagrelor conditioning effects are not additive to cardioprotection induced by direct NLRP3 inflammasome inhibition: role of RISK, NLRP3, and redox cascades publication-title: Oxid. Med. Cell. Longev. – volume: 46 start-page: 607 year: 2009 end-page: 609 ident: bib21 article-title: Multiple protective pathways against reperfusion injury: a SAFE path without Aktion? publication-title: J. Mol. Cell. Cardiol. – volume: 788 start-page: 280 year: 2016 end-page: 285 ident: bib76 article-title: U0126 attenuates ischemia/reperfusion-induced apoptosis and autophagy in myocardium through MEK/ERK/EGR-1 pathway publication-title: Eur. J. Pharmacol. – volume: 28 start-page: 1666 year: 2010 end-page: 1675 ident: bib27 article-title: Nitric oxide-independent stimulation of soluble guanylate cyclase reduces organ damage in experimental low-renin and high-renin models publication-title: J. Hypertens. – volume: 221 start-page: 226 year: 2012 end-page: 231 ident: bib70 article-title: Circulating endothelial and platelet derived microparticles reflect the size of myocardium at risk in patients with ST-elevation myocardial infarction publication-title: Atherosclerosis – volume: 109 start-page: 1302 year: 2011 end-page: 1308 ident: bib79 article-title: Mitochondrial STAT3 activation and cardioprotection by ischemic postconditioning in pigs with regional myocardial ischemia/reperfusion publication-title: Circ. Res. – volume: 120 start-page: 1477 year: 2017 end-page: 1486 ident: bib31 article-title: Critical issues for the translation of cardioprotection publication-title: Circ. Res. – volume: 113 start-page: 1 year: 2013 end-page: 11 ident: bib37 article-title: Biogenesis of extracellular vesicles (EV): exosomes, microvesicles, retrovirus-like vesicles, and apoptotic bodies publication-title: J. Neuro-Oncol. – volume: 24 start-page: 541 year: 2019 ident: bib19 article-title: Letter to the editor regarding article, “Role of glycogen synthase kinase following myocardial infarction and ischemia–reperfusion” publication-title: Apoptosis – volume: 66 start-page: 1142 year: 2014 end-page: 1174 ident: bib29 article-title: Interaction of risk factors, comorbidities, and comedications with ischemia/reperfusion injury and cardioprotection by preconditioning, postconditioning, and remote conditioning publication-title: Pharmacol. Rev. – volume: 89 start-page: 111 year: 2016 end-page: 122 ident: bib39 article-title: Microparticle analysis in disorders of hemostasis and thrombosis publication-title: Cytom. Part A – volume: 105 start-page: 771 year: 2010 end-page: 785 ident: bib23 article-title: Inhibition of permeability transition pore opening by mitochondrial STAT3 and its role in myocardial ischemia/reperfusion publication-title: Basic Res. Cardiol. – volume: 115 start-page: 1156 year: 2019 end-page: 1166 ident: bib34 article-title: Circulating blood cells and extracellular vesicles in acute cardioprotection publication-title: Cardiovasc. Res. – volume: 7 year: 2018 ident: bib36 article-title: Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines publication-title: J. Extracell. Vesicles – volume: 177 start-page: 5252 year: 2020 end-page: 5269 ident: bib30 article-title: Co-morbidities and co-medications as confounders of cardioprotection—does it matter in the clinical setting? publication-title: Br. J. Pharmacol. – volume: 19 start-page: 3572 year: 2018 ident: bib78 article-title: Effects of cardiovascular risk factors on cardiac STAT3 publication-title: Int. J. Mol. Sci. – volume: 110 start-page: 2440 year: 2007 end-page: 2448 ident: bib82 article-title: Endothelial progenitor cell − derived microvesicles activate an angiogenic program in endothelial cells by a horizontal transfer of mRNA publication-title: Blood – volume: 6 start-page: 287 year: 2016 end-page: 296 ident: bib66 article-title: Exosomes as therapeutic drug carriers and delivery vehicles across biological membranes: current perspectives and future challenges publication-title: Acta Pharm. Sin. B – volume: 97 start-page: 329 year: 2005 end-page: 336 ident: bib14 article-title: Protein kinase G transmits the cardioprotective signal from cytosol to mitochondria publication-title: Circ. Res. – volume: 228 start-page: 57 year: 2016 end-page: 71 ident: bib67 article-title: Microvesicles and exosomes: new players in metabolic and cardiovascular disease publication-title: J. Endocrinol. – volume: 23 start-page: 1 year: 2016 end-page: 9 ident: bib40 article-title: Microparticle and atherothrombotic diseases publication-title: J. Atheroscler. Thromb. – volume: 267 start-page: 2383 year: 1994 end-page: 2390 ident: bib63 article-title: Rat and rabbit heart infarction: effects of anesthesia, perfusate, risk zone, and method of infarct sizing publication-title: Am. J. Physiol. - Heart Circ. Physiol. – volume: 68 start-page: 75 year: 2014 end-page: 78 ident: bib74 article-title: Cardioprotection by remote ischemic preconditioning of the rat heart is mediated by extracellular vesicles publication-title: J. Mol. Cell. Cardiol. – volume: 285 start-page: 579 year: 2003 end-page: 588 ident: bib8 article-title: Inhibition of myocardial injury by ischemic postconditioning during reperfusion: comparison with ischemic preconditioning publication-title: Am. J. Physiol. - Heart Circ. Physiol. – volume: 8 start-page: 1394 year: 2012 end-page: 1396 ident: bib25 article-title: Autophagy is impaired in cardiac ischemia-reperfusion injury publication-title: Autophagy – volume: 10 start-page: 13 year: 2020 ident: bib53 article-title: The inflammatory cytokine IL-3 hampers cardioprotection mediated by endothelial cell-derived extracellular vesicles possibly via their protein cargo publication-title: Cells – volume: 113 start-page: 2 year: 2018 ident: bib17 article-title: The RISK pathway and beyond publication-title: Basic Res. Cardiol. – volume: 111 start-page: 27 year: 2016 ident: bib22 article-title: Understanding STAT3 signaling in cardiac ischemia publication-title: Basic Res. Cardiol. – volume: 63 start-page: 483 year: 2019 end-page: 492 ident: bib45 article-title: Remote ischaemic preconditioning increases serum extracellular vesicle concentrations with altered micro-RNA signature in CABG patients publication-title: Acta Anaesthesiol. Scand. – volume: 9 start-page: 47 year: 2011 ident: bib69 article-title: Enabling a robust scalable manufacturing process for therapeutic exosomes through oncogenic immortalization of human ESC-derived MSCs publication-title: J. Transl. Med. – volume: 6 start-page: 351 year: 2017 ident: bib72 article-title: Exosomes from Plasmodium-infected hosts inhibit tumor angiogenesis in a murine Lewis lung cancer model publication-title: Oncogenesis – volume: 15 year: 2020 ident: bib47 article-title: Extracellular vesicles isolated from patients undergoing remote ischemic preconditioning decrease hypoxia-evoked apoptosis of cardiomyoblasts after isoflurane but not propofol exposure publication-title: PLoS One – volume: 8 start-page: 10832 year: 2015 end-page: 108329 ident: bib46 article-title: Platelet-derived microvesicles are involved in cardio-protective effects of remote preconditioning publication-title: Int. J. Clin. Exp. Pathol. – volume: 8 start-page: 83395 year: 2013 ident: bib16 article-title: The MEK-ERK pathway is necessary for serine phosphorylation of mitochondrial STAT3 and ras-mediated transformation publication-title: PLoS One – volume: 3 start-page: 499 year: 2006 end-page: 506 ident: bib4 article-title: No-reflow phenomenon and prognosis in patients with acute myocardial infarction publication-title: Nat. Clin. Pract. Cardiovasc. Med. – volume: 13 start-page: 9775 year: 2015 end-page: 9782 ident: bib55 article-title: Differential detergent sensitivity of extracellular vesicle subpopulations publication-title: Org. Biomol. Chem. – volume: 74 start-page: 139 year: 2014 end-page: 150 ident: bib84 article-title: Cardiomyocytes mediate anti-angiogenesis in type 2 diabetic rats through the exosomal transfer of miR-320 into endothelial cells publication-title: J. Mol. Cell. Cardiol. – volume: 533 start-page: 17 year: 2020 end-page: 22 ident: bib65 article-title: Mice lacking DUSP6/8 have enhanced ERK1/2 activity and resistance to diet-induced obesity publication-title: Biochem. Biophys. Res. Commun. – volume: 74 start-page: 1124 year: 1986 end-page: 1136 ident: bib7 article-title: Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium publication-title: Circulation – volume: 13 start-page: 133 year: 2019 end-page: 144 ident: bib64 article-title: Improved loading of plasma-derived extracellular vesicles to encapsulate antitumor miRNAs publication-title: Mol. Ther. - Methods Clin. Dev. – volume: 95 start-page: 153 year: 2004 end-page: 158 ident: bib56 article-title: Plasmodium falciparum parasitized red blood cells modulate the production of endothelin-1 by human endothelial cells publication-title: Minerva Med. – volume: 283 start-page: 31246 year: 2008 end-page: 31255 ident: bib88 article-title: DUSP6 (MKP3) null mice show enhanced ERK1/2 phosphorylation at baseline and increased myocyte proliferation in the heart affecting disease susceptibility publication-title: J. Biol. Chem. – volume: 8 start-page: 15702 year: 2018 ident: bib41 article-title: Evaluation of the cardioprotective potential of extracellular vesicles – a systematic review and meta-analysis publication-title: Sci. Rep. – volume: 315 start-page: 159 year: 2018 end-page: 172 ident: bib51 article-title: Humoral transfer and intramyocardial signal transduction of protection by remote ischemic perconditioning in pigs, rats, and mice publication-title: Am. J. Physiol. - Heart Circ. Physiol. – volume: 10 start-page: 211 year: 2018 ident: bib57 article-title: α-cyclodextrin and α-cyclodextrin polymers as oxygen nanocarriers to limit hypoxia/reoxygenation injury: Implications from an in vitro model publication-title: Polymers – volume: 127 start-page: 1585 year: 2014 end-page: 1594 ident: bib83 article-title: Modulation of hypoxia-signaling pathways by extracellular linc-RoR publication-title: J. Cell Sci. – volume: 9 start-page: 875 year: 2018 ident: bib61 article-title: Cardioprotective properties of human platelets are lost in uncontrolled diabetes mellitus: a study in isolated rat hearts publication-title: Front. Physiol. – volume: 38 start-page: 774 year: 2017 end-page: 784 ident: bib2 article-title: The pathophysiology of acute myocardial infarction and strategies of protection beyond reperfusion: a continual challenge publication-title: Eur. Heart J. – volume: 288 start-page: 971 year: 2005 end-page: 976 ident: bib18 article-title: Ischemic preconditioning protects by activating prosurvival kinases at reperfusion publication-title: Am. J. Physiol. - Heart Circ. Physiol. – volume: 394 start-page: 1415 year: 2019 end-page: 1424 ident: bib32 article-title: Effect of remote ischaemic conditioning on clinical outcomes in patients with acute myocardial infarction (CONDI-2/ERIC-PPCI): a single-blind randomised controlled trial publication-title: Lancet – volume: 67 start-page: 30 year: 2005 end-page: 38 ident: bib38 article-title: Platelet-derived microparticles induce angiogenesis and stimulate post-ischemic revascularization publication-title: Cardiovasc. Res. – volume: 106 start-page: 135 year: 2011 end-page: 145 ident: bib73 article-title: Remote postconditioning by humoral factors in effluent from ischemic preconditioned rat hearts is mediated via PI3K/Akt-dependent cell-survival signaling at reperfusion publication-title: Basic Res. Cardiol. – volume: 2 start-page: 450 year: 2005 end-page: 456 ident: bib10 article-title: Remote ischemic preconditioning provides early and late protection against endothelial ischemia-reperfusion injury in humans: role of the autonomic nervous system publication-title: J. Am. Coll. Cardiol. – volume: 6 start-page: 111 year: 2012 end-page: 115 ident: bib20 article-title: STAT5 activation and cardioprotection by remote ischemic preconditioning in humans publication-title: Circ. Res. – volume: 14 start-page: 1435 year: 2020 end-page: 1534 ident: bib1 article-title: 2018 ESC/EACTS Guidelines on myocardial revascularization publication-title: EuroIntervention – volume: 112 start-page: 2143 year: 2005 end-page: 2148 ident: bib9 article-title: Postconditioning the human heart publication-title: Circulation – volume: 111 start-page: 70 year: 2016 ident: bib6 article-title: Ischaemic conditioning and targeting reperfusion injury: a 30 year voyage of discovery publication-title: Basic Res. Cardiol. – volume: 14 start-page: 180 year: 2013 end-page: 186 ident: bib12 article-title: Genesis of remote conditioning: action at a distance-hypotheses non fingo? publication-title: J. Cardiovasc. Med. – volume: 61 start-page: 427 year: 2004 end-page: 436 ident: bib26 article-title: Protein kinase activation and myocardial ischemia/reperfusion injury publication-title: Cardiovasc. Res. – volume: 286 start-page: 1576 year: 2011 end-page: 1587 ident: bib81 article-title: Opposing actions of extracellular signal-regulated kinase (ERK) and signal transducer and activator of transcription 3 (STAT3) in regulating microtubule stabilization during cardiac hypertrophy publication-title: J. Biol. Chem. – volume: 257 start-page: 1 year: 2018 end-page: 6 ident: bib49 article-title: The EUROpean and Chinese cardiac and renal Remote Ischemic Preconditioning Study (EURO-CRIPS CardioGroup I): a randomized controlled trial publication-title: Int. J. Cardiol. – volume: 31 start-page: 577 year: 2010 end-page: 586 ident: bib62 article-title: Dual specificity phosphatase 6 (DUSP6) is an ETS-regulated negative feedback mediator of oncogenic ERK signaling in lung cancer cells publication-title: Carcinogenesis – volume: 145 year: 2018 ident: bib89 article-title: Dusp6 attenuates Ras/MAPK signaling to limit zebrafish heart regeneration publication-title: Development (Cambridge, England) – volume: 13 start-page: 193 year: 2016 end-page: 209 ident: bib28 article-title: Ischaemic conditioning and reperfusion injury publication-title: Nat. Rev. Cardiol. – volume: 6 start-page: 351 year: 2017 ident: 10.1016/j.phrs.2021.105715_bib72 article-title: Exosomes from Plasmodium-infected hosts inhibit tumor angiogenesis in a murine Lewis lung cancer model publication-title: Oncogenesis doi: 10.1038/oncsis.2017.52 – volume: 145 year: 2018 ident: 10.1016/j.phrs.2021.105715_bib89 article-title: Dusp6 attenuates Ras/MAPK signaling to limit zebrafish heart regeneration publication-title: Development (Cambridge, England) doi: 10.1242/dev.157206 – volume: 38 start-page: 774 year: 2017 ident: 10.1016/j.phrs.2021.105715_bib2 article-title: The pathophysiology of acute myocardial infarction and strategies of protection beyond reperfusion: a continual challenge publication-title: Eur. Heart J. – volume: 24 start-page: 541 year: 2019 ident: 10.1016/j.phrs.2021.105715_bib19 article-title: Letter to the editor regarding article, “Role of glycogen synthase kinase following myocardial infarction and ischemia–reperfusion” publication-title: Apoptosis doi: 10.1007/s10495-019-01546-8 – volume: 38 start-page: 1359 year: 2016 ident: 10.1016/j.phrs.2021.105715_bib52 article-title: Charge-based precipitation of extracellular vesicles publication-title: Int. J. Mol. Med. doi: 10.3892/ijmm.2016.2759 – volume: 123 start-page: 786 year: 2015 ident: 10.1016/j.phrs.2021.105715_bib87 article-title: MicroRNA-21 mediates isoflurane-induced cardioprotection against ischemia-reperfusion injury via Akt/Nitric oxide synthase/mitochondrial permeability transition pore pathway publication-title: Anesthesiology doi: 10.1097/ALN.0000000000000807 – volume: 2018 year: 2018 ident: 10.1016/j.phrs.2021.105715_bib86 article-title: MicroRNA-132, delivered by mesenchymal stem cell-derived exosomes, promote angiogenesis in myocardial infarction publication-title: Stem Cells Int. doi: 10.1155/2018/3290372 – volume: 7 year: 2018 ident: 10.1016/j.phrs.2021.105715_bib36 article-title: Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines publication-title: J. Extracell. Vesicles doi: 10.1080/20013078.2018.1535750 – volume: 135 year: 2020 ident: 10.1016/j.phrs.2021.105715_bib43 article-title: Extracellular vesicles and cardiovascular system: biomarkers and cardioprotective effectors publication-title: Vasc. Pharmacol. doi: 10.1016/j.vph.2020.106790 – volume: 13 start-page: 9775 year: 2015 ident: 10.1016/j.phrs.2021.105715_bib55 article-title: Differential detergent sensitivity of extracellular vesicle subpopulations publication-title: Org. Biomol. Chem. doi: 10.1039/C5OB01451D – volume: 8 start-page: 83395 year: 2013 ident: 10.1016/j.phrs.2021.105715_bib16 article-title: The MEK-ERK pathway is necessary for serine phosphorylation of mitochondrial STAT3 and ras-mediated transformation publication-title: PLoS One doi: 10.1371/journal.pone.0083395 – volume: 15 year: 2020 ident: 10.1016/j.phrs.2021.105715_bib47 article-title: Extracellular vesicles isolated from patients undergoing remote ischemic preconditioning decrease hypoxia-evoked apoptosis of cardiomyoblasts after isoflurane but not propofol exposure publication-title: PLoS One doi: 10.1371/journal.pone.0228948 – volume: 87 start-page: 20 year: 2016 ident: 10.1016/j.phrs.2021.105715_bib80 article-title: Mitochondrial STAT3: powering up a potent factor publication-title: Cytokine doi: 10.1016/j.cyto.2016.05.019 – volume: 89 start-page: 111 year: 2016 ident: 10.1016/j.phrs.2021.105715_bib39 article-title: Microparticle analysis in disorders of hemostasis and thrombosis publication-title: Cytom. Part A doi: 10.1002/cyto.a.22647 – volume: 788 start-page: 280 year: 2016 ident: 10.1016/j.phrs.2021.105715_bib76 article-title: U0126 attenuates ischemia/reperfusion-induced apoptosis and autophagy in myocardium through MEK/ERK/EGR-1 pathway publication-title: Eur. J. Pharmacol. doi: 10.1016/j.ejphar.2016.06.038 – volume: 288 start-page: 971 year: 2005 ident: 10.1016/j.phrs.2021.105715_bib18 article-title: Ischemic preconditioning protects by activating prosurvival kinases at reperfusion publication-title: Am. J. Physiol. - Heart Circ. Physiol. doi: 10.1152/ajpheart.00374.2004 – volume: 74 start-page: 1124 year: 1986 ident: 10.1016/j.phrs.2021.105715_bib7 article-title: Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium publication-title: Circulation doi: 10.1161/01.CIR.74.5.1124 – volume: 67 start-page: 30 year: 2005 ident: 10.1016/j.phrs.2021.105715_bib38 article-title: Platelet-derived microparticles induce angiogenesis and stimulate post-ischemic revascularization publication-title: Cardiovasc. Res. doi: 10.1016/j.cardiores.2005.04.007 – volume: 111 start-page: 70 year: 2016 ident: 10.1016/j.phrs.2021.105715_bib6 article-title: Ischaemic conditioning and targeting reperfusion injury: a 30 year voyage of discovery publication-title: Basic Res. Cardiol. doi: 10.1007/s00395-016-0588-8 – volume: 20 start-page: 2164 year: 2019 ident: 10.1016/j.phrs.2021.105715_bib75 article-title: ERK: A key player in the pathophysiology of cardiac hypertrophy publication-title: Int. J. Mol. Sci. doi: 10.3390/ijms20092164 – volume: 112 start-page: 2143 year: 2005 ident: 10.1016/j.phrs.2021.105715_bib9 article-title: Postconditioning the human heart publication-title: Circulation doi: 10.1161/CIRCULATIONAHA.105.558122 – volume: 111 start-page: 27 year: 2016 ident: 10.1016/j.phrs.2021.105715_bib22 article-title: Understanding STAT3 signaling in cardiac ischemia publication-title: Basic Res. Cardiol. doi: 10.1007/s00395-016-0543-8 – volume: 117 start-page: 279 year: 2015 ident: 10.1016/j.phrs.2021.105715_bib13 article-title: Across-species transfer of protection by remote ischemic preconditioning with species-specific myocardial signal transduction by reperfusion injury salvage kinase and survival activating factor enhancement pathways publication-title: Circ. Res. doi: 10.1161/CIRCRESAHA.117.306878 – volume: 8 start-page: 218 year: 2020 ident: 10.1016/j.phrs.2021.105715_bib48 article-title: Changes in circulating extracellular vesicles in patients with st-elevation myocardial infarction and potential effects of remote ischemic conditioning-a randomized controlled trial publication-title: Biomedicines doi: 10.3390/biomedicines8070218 – volume: 74 start-page: 139 year: 2014 ident: 10.1016/j.phrs.2021.105715_bib84 article-title: Cardiomyocytes mediate anti-angiogenesis in type 2 diabetic rats through the exosomal transfer of miR-320 into endothelial cells publication-title: J. Mol. Cell. Cardiol. doi: 10.1016/j.yjmcc.2014.05.001 – volume: 2 start-page: 450 year: 2005 ident: 10.1016/j.phrs.2021.105715_bib10 article-title: Remote ischemic preconditioning provides early and late protection against endothelial ischemia-reperfusion injury in humans: role of the autonomic nervous system publication-title: J. Am. Coll. Cardiol. doi: 10.1016/j.jacc.2005.04.044 – volume: 8 start-page: 10832 year: 2015 ident: 10.1016/j.phrs.2021.105715_bib46 article-title: Platelet-derived microvesicles are involved in cardio-protective effects of remote preconditioning publication-title: Int. J. Clin. Exp. Pathol. – volume: 1 start-page: 3 year: 1970 ident: 10.1016/j.phrs.2021.105715_bib50 article-title: Kinetics and signal activation properties of circulating factor(s) from healthy volunteers undergoing remote ischemic pre-conditioning publication-title: JACC: Basic Transl. Sci. – volume: 109 start-page: 423 year: 2014 ident: 10.1016/j.phrs.2021.105715_bib85 article-title: Microrna-144 is a circulating effector of remote ischemic preconditioning publication-title: Basic Res. Cardiol. doi: 10.1007/s00395-014-0423-z – volume: 31 start-page: 577 year: 2010 ident: 10.1016/j.phrs.2021.105715_bib62 article-title: Dual specificity phosphatase 6 (DUSP6) is an ETS-regulated negative feedback mediator of oncogenic ERK signaling in lung cancer cells publication-title: Carcinogenesis doi: 10.1093/carcin/bgq020 – volume: 177 start-page: 5252 year: 2020 ident: 10.1016/j.phrs.2021.105715_bib30 article-title: Co-morbidities and co-medications as confounders of cardioprotection—does it matter in the clinical setting? publication-title: Br. J. Pharmacol. doi: 10.1111/bph.14839 – volume: 23 start-page: 1 year: 2016 ident: 10.1016/j.phrs.2021.105715_bib40 article-title: Microparticle and atherothrombotic diseases publication-title: J. Atheroscler. Thromb. doi: 10.5551/jat.32326 – volume: 9 start-page: 1326 year: 2018 ident: 10.1016/j.phrs.2021.105715_bib54 article-title: Systematic methodological evaluation of a multiplex bead-based flow cytometry assay for detection of extracellular vesicle surface signatures publication-title: Front. Immunol. doi: 10.3389/fimmu.2018.01326 – volume: 228 start-page: 57 year: 2016 ident: 10.1016/j.phrs.2021.105715_bib67 article-title: Microvesicles and exosomes: new players in metabolic and cardiovascular disease publication-title: J. Endocrinol. doi: 10.1530/JOE-15-0201 – volume: 14 start-page: 1435 year: 2020 ident: 10.1016/j.phrs.2021.105715_bib1 article-title: 2018 ESC/EACTS Guidelines on myocardial revascularization publication-title: EuroIntervention doi: 10.4244/EIJY19M01_01 – volume: 285 start-page: 579 year: 2003 ident: 10.1016/j.phrs.2021.105715_bib8 article-title: Inhibition of myocardial injury by ischemic postconditioning during reperfusion: comparison with ischemic preconditioning publication-title: Am. J. Physiol. - Heart Circ. Physiol. doi: 10.1152/ajpheart.01064.2002 – volume: 20 start-page: 5024 year: 2019 ident: 10.1016/j.phrs.2021.105715_bib42 article-title: Ischemia reperfusion injury: mechanisms of damage/protection and novel strategies for cardiac recovery/regeneration publication-title: Int. J. Mol. Sci. doi: 10.3390/ijms20205024 – volume: 46 start-page: 607 year: 2009 ident: 10.1016/j.phrs.2021.105715_bib21 article-title: Multiple protective pathways against reperfusion injury: a SAFE path without Aktion? publication-title: J. Mol. Cell. Cardiol. doi: 10.1016/j.yjmcc.2009.01.003 – volume: 2020 year: 2020 ident: 10.1016/j.phrs.2021.105715_bib59 article-title: Ticagrelor conditioning effects are not additive to cardioprotection induced by direct NLRP3 inflammasome inhibition: role of RISK, NLRP3, and redox cascades publication-title: Oxid. Med. Cell. Longev. doi: 10.1155/2020/9219825 – volume: 9 start-page: 1169 year: 2018 ident: 10.1016/j.phrs.2021.105715_bib68 article-title: Exosomes from human cardiac progenitor cells for therapeutic applications: development of a GMP-grade manufacturing method publication-title: Front. Physiol. doi: 10.3389/fphys.2018.01169 – volume: 19 start-page: 4544 year: 2013 ident: 10.1016/j.phrs.2021.105715_bib24 article-title: Cardioprotection techniques: preconditioning, postconditioning and remote con-ditioning (basic science) publication-title: Curr. Pharm. Des. doi: 10.2174/1381612811319250004 – volume: 267 start-page: 2383 year: 1994 ident: 10.1016/j.phrs.2021.105715_bib63 article-title: Rat and rabbit heart infarction: effects of anesthesia, perfusate, risk zone, and method of infarct sizing publication-title: Am. J. Physiol. - Heart Circ. Physiol. doi: 10.1152/ajpheart.1994.267.6.H2383 – volume: 9 start-page: 47 year: 2011 ident: 10.1016/j.phrs.2021.105715_bib69 article-title: Enabling a robust scalable manufacturing process for therapeutic exosomes through oncogenic immortalization of human ESC-derived MSCs publication-title: J. Transl. Med. doi: 10.1186/1479-5876-9-47 – volume: 13 start-page: 193 year: 2016 ident: 10.1016/j.phrs.2021.105715_bib28 article-title: Ischaemic conditioning and reperfusion injury publication-title: Nat. Rev. Cardiol. doi: 10.1038/nrcardio.2016.5 – volume: 286 start-page: 1576 year: 2011 ident: 10.1016/j.phrs.2021.105715_bib81 article-title: Opposing actions of extracellular signal-regulated kinase (ERK) and signal transducer and activator of transcription 3 (STAT3) in regulating microtubule stabilization during cardiac hypertrophy publication-title: J. Biol. Chem. doi: 10.1074/jbc.M110.128157 – volume: 113 start-page: 2 year: 2018 ident: 10.1016/j.phrs.2021.105715_bib17 article-title: The RISK pathway and beyond publication-title: Basic Res. Cardiol. doi: 10.1007/s00395-017-0662-x – volume: 66 start-page: 1142 year: 2014 ident: 10.1016/j.phrs.2021.105715_bib29 article-title: Interaction of risk factors, comorbidities, and comedications with ischemia/reperfusion injury and cardioprotection by preconditioning, postconditioning, and remote conditioning publication-title: Pharmacol. Rev. doi: 10.1124/pr.113.008300 – volume: 110 start-page: 2440 year: 2007 ident: 10.1016/j.phrs.2021.105715_bib82 article-title: Endothelial progenitor cell − derived microvesicles activate an angiogenic program in endothelial cells by a horizontal transfer of mRNA publication-title: Blood doi: 10.1182/blood-2007-03-078709 – volume: 123 start-page: 100 year: 2018 ident: 10.1016/j.phrs.2021.105715_bib44 article-title: Intra-cardiac release of extracellular vesicles shapes inflammation following myocardial infarction short communication publication-title: Circ. Res. doi: 10.1161/CIRCRESAHA.117.311326 – volume: 83 start-page: 165 year: 2009 ident: 10.1016/j.phrs.2021.105715_bib5 article-title: Lethal reperfusion injury in acute myocardial infarction: facts and unresolved issues publication-title: Cardiovasc. Res. doi: 10.1093/cvr/cvp185 – volume: 106 start-page: 135 year: 2011 ident: 10.1016/j.phrs.2021.105715_bib73 article-title: Remote postconditioning by humoral factors in effluent from ischemic preconditioned rat hearts is mediated via PI3K/Akt-dependent cell-survival signaling at reperfusion publication-title: Basic Res. Cardiol. doi: 10.1007/s00395-010-0133-0 – volume: 97 start-page: 329 year: 2005 ident: 10.1016/j.phrs.2021.105715_bib14 article-title: Protein kinase G transmits the cardioprotective signal from cytosol to mitochondria publication-title: Circ. Res. doi: 10.1161/01.RES.0000178451.08719.5b – volume: 115 start-page: 1156 year: 2019 ident: 10.1016/j.phrs.2021.105715_bib34 article-title: Circulating blood cells and extracellular vesicles in acute cardioprotection publication-title: Cardiovasc. Res. doi: 10.1093/cvr/cvy314 – volume: 257 start-page: 1 year: 2018 ident: 10.1016/j.phrs.2021.105715_bib49 article-title: The EUROpean and Chinese cardiac and renal Remote Ischemic Preconditioning Study (EURO-CRIPS CardioGroup I): a randomized controlled trial publication-title: Int. J. Cardiol. doi: 10.1016/j.ijcard.2017.12.033 – volume: 9 start-page: 875 year: 2018 ident: 10.1016/j.phrs.2021.105715_bib61 article-title: Cardioprotective properties of human platelets are lost in uncontrolled diabetes mellitus: a study in isolated rat hearts publication-title: Front. Physiol. doi: 10.3389/fphys.2018.00875 – volume: 357 start-page: 1121 year: 2007 ident: 10.1016/j.phrs.2021.105715_bib3 article-title: Myocardial reperfusion injury publication-title: N. Engl. J. Med. doi: 10.1056/NEJMra071667 – volume: 61 start-page: 427 year: 2004 ident: 10.1016/j.phrs.2021.105715_bib26 article-title: Protein kinase activation and myocardial ischemia/reperfusion injury publication-title: Cardiovasc. Res. doi: 10.1016/j.cardiores.2003.09.031 – volume: 10 start-page: 211 year: 2018 ident: 10.1016/j.phrs.2021.105715_bib57 article-title: α-cyclodextrin and α-cyclodextrin polymers as oxygen nanocarriers to limit hypoxia/reoxygenation injury: Implications from an in vitro model publication-title: Polymers doi: 10.3390/polym10020211 – volume: 315 start-page: 159 year: 2018 ident: 10.1016/j.phrs.2021.105715_bib51 article-title: Humoral transfer and intramyocardial signal transduction of protection by remote ischemic perconditioning in pigs, rats, and mice publication-title: Am. J. Physiol. - Heart Circ. Physiol. doi: 10.1152/ajpheart.00152.2018 – volume: 95 start-page: 153 year: 2004 ident: 10.1016/j.phrs.2021.105715_bib56 article-title: Plasmodium falciparum parasitized red blood cells modulate the production of endothelin-1 by human endothelial cells publication-title: Minerva Med. – volume: 3 start-page: 499 year: 2006 ident: 10.1016/j.phrs.2021.105715_bib4 article-title: No-reflow phenomenon and prognosis in patients with acute myocardial infarction publication-title: Nat. Clin. Pract. Cardiovasc. Med. doi: 10.1038/ncpcardio0632 – volume: 998 start-page: 285 year: 2017 ident: 10.1016/j.phrs.2021.105715_bib33 article-title: Exosomes: outlook for future cell-free cardiovascular disease therapy publication-title: Adv. Exp. Med. Biol. doi: 10.1007/978-981-10-4397-0_19 – volume: 116 start-page: 674 year: 2015 ident: 10.1016/j.phrs.2021.105715_bib15 article-title: Molecular basis of cardioprotection signal transduction in ischemic pre-, post-, and remote conditioning publication-title: Circ. Res. doi: 10.1161/CIRCRESAHA.116.305348 – volume: 6 start-page: 111 year: 2012 ident: 10.1016/j.phrs.2021.105715_bib20 article-title: STAT5 activation and cardioprotection by remote ischemic preconditioning in humans publication-title: Circ. Res. doi: 10.1161/CIRCRESAHA.111.259556 – volume: 6 start-page: 287 year: 2016 ident: 10.1016/j.phrs.2021.105715_bib66 article-title: Exosomes as therapeutic drug carriers and delivery vehicles across biological membranes: current perspectives and future challenges publication-title: Acta Pharm. Sin. B doi: 10.1016/j.apsb.2016.02.001 – volume: 105 start-page: 771 year: 2010 ident: 10.1016/j.phrs.2021.105715_bib23 article-title: Inhibition of permeability transition pore opening by mitochondrial STAT3 and its role in myocardial ischemia/reperfusion publication-title: Basic Res. Cardiol. doi: 10.1007/s00395-010-0124-1 – volume: 109 start-page: 1302 year: 2011 ident: 10.1016/j.phrs.2021.105715_bib79 article-title: Mitochondrial STAT3 activation and cardioprotection by ischemic postconditioning in pigs with regional myocardial ischemia/reperfusion publication-title: Circ. Res. doi: 10.1161/CIRCRESAHA.111.255604 – volume: 12 start-page: 650 year: 2014 ident: 10.1016/j.phrs.2021.105715_bib77 article-title: From ischemic conditioning to ‘hyperconditioning’: clinical phenomenon and basic science opportunity publication-title: Dose-Response doi: 10.2203/dose-response.14-035.Whittaker – volume: 113 start-page: 1 year: 2013 ident: 10.1016/j.phrs.2021.105715_bib37 article-title: Biogenesis of extracellular vesicles (EV): exosomes, microvesicles, retrovirus-like vesicles, and apoptotic bodies publication-title: J. Neuro-Oncol. doi: 10.1007/s11060-013-1084-8 – volume: 6 start-page: 30110 year: 2016 ident: 10.1016/j.phrs.2021.105715_bib71 article-title: Pancreatic cancer cell exosome-mediated macrophage reprogramming and the role of MicroRNAs 155 and 125b2 transfection using nanoparticle delivery systems publication-title: Sci. Rep. doi: 10.1038/srep30110 – volume: 120 start-page: 1477 year: 2017 ident: 10.1016/j.phrs.2021.105715_bib31 article-title: Critical issues for the translation of cardioprotection publication-title: Circ. Res. doi: 10.1161/CIRCRESAHA.117.310820 – volume: 8 start-page: 15702 year: 2018 ident: 10.1016/j.phrs.2021.105715_bib41 article-title: Evaluation of the cardioprotective potential of extracellular vesicles – a systematic review and meta-analysis publication-title: Sci. Rep. doi: 10.1038/s41598-018-33862-5 – volume: 476 start-page: 689 year: 2020 ident: 10.1016/j.phrs.2021.105715_bib58 article-title: MicroRNA-20a-5p suppresses tumor angiogenesis of non-small cell lung cancer through RRM2-mediated PI3K/Akt signaling pathway publication-title: Mol. Cell. Biochem. doi: 10.1007/s11010-020-03936-y – volume: 127 start-page: 1585 year: 2014 ident: 10.1016/j.phrs.2021.105715_bib83 article-title: Modulation of hypoxia-signaling pathways by extracellular linc-RoR publication-title: J. Cell Sci. – volume: 87 start-page: 893 year: 1993 ident: 10.1016/j.phrs.2021.105715_bib11 article-title: Regional ischemic “preconditioning” protects remote virgin myocardium from subsequent sustained coronary occlusion publication-title: Circulation doi: 10.1161/01.CIR.87.3.893 – volume: 14 start-page: 180 year: 2013 ident: 10.1016/j.phrs.2021.105715_bib12 article-title: Genesis of remote conditioning: action at a distance-hypotheses non fingo? publication-title: J. Cardiovasc. Med. doi: 10.2459/JCM.0b013e328358c8eb – volume: 394 start-page: 1415 year: 2019 ident: 10.1016/j.phrs.2021.105715_bib32 article-title: Effect of remote ischaemic conditioning on clinical outcomes in patients with acute myocardial infarction (CONDI-2/ERIC-PPCI): a single-blind randomised controlled trial publication-title: Lancet doi: 10.1016/S0140-6736(19)32039-2 – volume: 28 start-page: 1666 year: 2010 ident: 10.1016/j.phrs.2021.105715_bib27 article-title: Nitric oxide-independent stimulation of soluble guanylate cyclase reduces organ damage in experimental low-renin and high-renin models publication-title: J. Hypertens. doi: 10.1097/HJH.0b013e32833b558c – volume: 20 start-page: 2140 year: 2019 ident: 10.1016/j.phrs.2021.105715_bib35 article-title: Effect of ischemic preconditioning and postconditioning on exosome-rich fraction microrna levels, in relation with electrophysiological parameters and ventricular arrhythmia in experimental closed-chest reperfused myocardial infarction publication-title: Int. J. Mol. Sci. doi: 10.3390/ijms20092140 – volume: 13 start-page: 133 year: 2019 ident: 10.1016/j.phrs.2021.105715_bib64 article-title: Improved loading of plasma-derived extracellular vesicles to encapsulate antitumor miRNAs publication-title: Mol. Ther. - Methods Clin. Dev. doi: 10.1016/j.omtm.2019.01.001 – volume: 19 start-page: 3572 year: 2018 ident: 10.1016/j.phrs.2021.105715_bib78 article-title: Effects of cardiovascular risk factors on cardiac STAT3 publication-title: Int. J. Mol. Sci. doi: 10.3390/ijms19113572 – volume: 8 start-page: 1394 year: 2012 ident: 10.1016/j.phrs.2021.105715_bib25 article-title: Autophagy is impaired in cardiac ischemia-reperfusion injury publication-title: Autophagy doi: 10.4161/auto.21036 – volume: 221 start-page: 226 year: 2012 ident: 10.1016/j.phrs.2021.105715_bib70 article-title: Circulating endothelial and platelet derived microparticles reflect the size of myocardium at risk in patients with ST-elevation myocardial infarction publication-title: Atherosclerosis doi: 10.1016/j.atherosclerosis.2011.12.025 – volume: 10 start-page: 13 year: 2020 ident: 10.1016/j.phrs.2021.105715_bib53 article-title: The inflammatory cytokine IL-3 hampers cardioprotection mediated by endothelial cell-derived extracellular vesicles possibly via their protein cargo publication-title: Cells doi: 10.3390/cells10010013 – volume: 283 start-page: 31246 year: 2008 ident: 10.1016/j.phrs.2021.105715_bib88 article-title: DUSP6 (MKP3) null mice show enhanced ERK1/2 phosphorylation at baseline and increased myocyte proliferation in the heart affecting disease susceptibility publication-title: J. Biol. Chem. doi: 10.1074/jbc.M806085200 – volume: 63 start-page: 483 year: 2019 ident: 10.1016/j.phrs.2021.105715_bib45 article-title: Remote ischaemic preconditioning increases serum extracellular vesicle concentrations with altered micro-RNA signature in CABG patients publication-title: Acta Anaesthesiol. Scand. doi: 10.1111/aas.13296 – volume: 34 start-page: 551 year: 2021 ident: 10.1016/j.phrs.2021.105715_bib60 article-title: Chronic empagliflozin treatment reduces myocardial infarct size in nondiabetic mice through STAT-3-mediated protection on microvascular endothelial cells and reduction of oxidative stress publication-title: Antioxid. Redox Signal. doi: 10.1089/ars.2019.7923 – volume: 68 start-page: 75 year: 2014 ident: 10.1016/j.phrs.2021.105715_bib74 article-title: Cardioprotection by remote ischemic preconditioning of the rat heart is mediated by extracellular vesicles publication-title: J. Mol. Cell. Cardiol. doi: 10.1016/j.yjmcc.2014.01.004 – volume: 533 start-page: 17 year: 2020 ident: 10.1016/j.phrs.2021.105715_bib65 article-title: Mice lacking DUSP6/8 have enhanced ERK1/2 activity and resistance to diet-induced obesity publication-title: Biochem. Biophys. Res. Commun. doi: 10.1016/j.bbrc.2020.08.106 |
| SSID | ssj0009410 |
| Score | 2.4940248 |
| Snippet | The relevance of extracellular vesicles (EV) as mediators of cardiac damage or recovery upon Ischemia Reperfusion Injury (IRI) and Remote Ischemic... |
| SourceID | proquest pubmed crossref elsevier |
| SourceType | Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 105715 |
| SubjectTerms | ACS Acute Coronary Syndrome - blood Acute Coronary Syndrome - diagnosis Acute Coronary Syndrome - therapy Aged Animals Arm - blood supply Case-Control Studies Cell Line Disease Models, Animal Double-Blind Method Dual Specificity Phosphatase 6 - metabolism Endothelial Cells - metabolism Extracellular Signal-Regulated MAP Kinases - metabolism Extracellular vesicles Extracellular Vesicles - metabolism Extracellular Vesicles - transplantation Female Humans Ischemia/reperfusion injury Ischemic Preconditioning, Myocardial - adverse effects Male Middle Aged Myocardial Reperfusion Injury - diagnosis Myocardial Reperfusion Injury - etiology Myocardial Reperfusion Injury - metabolism Myocardial Reperfusion Injury - prevention & control Myocytes, Cardiac - metabolism Myocytes, Cardiac - pathology Percutaneous Coronary Intervention - adverse effects Phosphorylation Rats Rats, Wistar Regional Blood Flow Salvage pathways STAT3 Transcription Factor - metabolism Time Factors Treatment Outcome |
| Title | Extracellular vesicles from patients with Acute Coronary Syndrome impact on ischemia-reperfusion injury |
| URI | https://dx.doi.org/10.1016/j.phrs.2021.105715 https://www.ncbi.nlm.nih.gov/pubmed/34111564 https://www.proquest.com/docview/2540520152 |
| Volume | 170 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Na9wwEBUhveRSmn5ukgYVSi6NupYtfx2XJWGbkBBIArmZsSUVh9a7eL0he-lv74wlZym0OfRoI2GjN5p5EjNvGPusyRAgtwIqq4TSNhSg41LIDE8TgVFW9e3bLi6T2a06u4vvtth0qIWhtErv-51P7721fzP2qzle1PX4WpJ6eoL8mFREc1fBrlKy8q-_NmkeuRoUCSJBo33hjMvxwvUiye5Q9u1uqTXu34PTv8hnH4ROX7GXnj3yifvBXbZlmtfs6MrJT6-P-c2mmmp5zI_41UaYev2GfT957Fqgq3rKPeUPZtnnxHEqMeFeYHXJ6WaWT6pVZ_iU5A2gXfNrr2vAXVElnze8xmOx-VmDaM3CtHZFt268bu4Ro7fs9vTkZjoTvtGCqBCQTsSgMUqXUJVxZJMMpM6ypEyRKYSAB54qkpXBnasgyiwE6KpTK1Nd5jYMtAwyE71j2828MR8Yz3QOWQRaIU9SNk2QjZRgTawg0JDLcsTksMJF5VXIqRnGj2JIN7svCJWCUCkcKiP25WnOwmlwPDs6HoAr_rCkAoPEs_M-DSgXuMUIDGjMfIWDiNWGtBoj9t7B__QfSAIk6e3s_edX99kOPbmUwgO23bUr8xFpTlce9nZ8yF5Mvp3PLn8DVb397w |
| linkProvider | Elsevier |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3fa9swEBYlfdhexn4v635oMPqymli27NiPIbSkaxsKTaFv4mxJxWVzguOU5b_fnSU3DLY-7NW2sLhPuvsk7r5j7KumhQC5DaC0MpDaRgHopAhEhqeJ0Egru_ZtF_N0di2_3yQ3e2za18JQWqX3_c6nd97aPxl5a45WVTW6EqSeniI_JhXRnCrY90mdKhmw_cnp2Wy-096VvShBHNAAXzvj0rzQZKTaHYmu4y11x_17fPoX_-zi0Mlz9swTSD5xc3zB9kz9kh1eOgXq7RFf7Aqq1kf8kF_utKm3r9jt8a-2Abqtp_RTfm_WXVocpyoT7jVW15wuZ_mk3LSGT0nhAJotv_LSBtzVVfJlzSs8GZufFQSNWZnGbujijVf1HcL0ml2fHC-ms8D3WghKxKQNEtAYqAsoiyS2aQZCZ1lajJEsRIBnnjIWpcHNKyHOLITorcdWjHWR2yjUIsxM_IYN6mVt3jGe6RyyGLREqiTtOEVCUoA1iYRQQy6KIRO9hVXphcipH8YP1Wec3SlCRREqyqEyZN8exqycDMejXyc9cOqPxaQwTjw67kuPssJdRmBAbZYb_IiIbUTWGLK3Dv6HeSAPECS58_4___qZPZktLs7V-en87IA9pTcuw_ADG7TNxnxE1tMWn_yq_g0CVwCv |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Extracellular+vesicles+from+patients+with+Acute+Coronary+Syndrome+impact+on+ischemia-reperfusion+injury&rft.jtitle=Pharmacological+research&rft.au=D%27Ascenzo%2C+Fabrizio&rft.au=Femmin%C3%B2%2C+Saveria&rft.au=Ravera%2C+Francesco&rft.au=Angelini%2C+Filippo&rft.date=2021-08-01&rft.issn=1096-1186&rft.eissn=1096-1186&rft.volume=170&rft.spage=105715&rft_id=info:doi/10.1016%2Fj.phrs.2021.105715&rft.externalDBID=NO_FULL_TEXT |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1043-6618&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1043-6618&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1043-6618&client=summon |